Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2021 Sep 1;16(9):e0257142. doi: 10.1371/journal.pone.0257142

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

Paul Jank, Claire Gehlhaar, Bianca Lederer, Caterina Fontanella, Andreas Schneeweiss, Thomas Karn, Frederik Marmé, Hans-Peter Sinn, Marion van Mackelenbergh, Bruno Sinn, Dirk-Michael Zahm, Barbara Ingold-Heppner, Christian Schem, Elmar Stickeler, Peter A Fasching, Valentina Nekljudova, Eliane Tabea Taube, Frank Heppner, Volkmar Müller, Carsten Denkert, Sibylle Loibl
PMCID: PMC8409660  PMID: 34469495

The third, fourth, and fifth authors’ names appear incorrectly. The correct names are: Bianca Lederer, Caterina Fontanella, and Andreas Schneeweiss. The correct citation is: Jank P, Gehlhaar C, Lederer B, Fontanella C, Schneeweiss A, Karn T, et al. (2020) MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial. PLoS ONE 15(8): e0238021. https://doi.org/10.1371/journal.pone.0238021

Reference

  • 1.Jank P, Gehlhaar C, Bianca L, Caterina F, Andreas S, Karn T, et al. (2020) MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial. PLoS ONE 15(8): e0238021. 10.1371/journal.pone.0238021 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES